Cyclophosphamide/Doxorubicin/Fluorouracil/Levamisole Regimen

Preferred Label : Cyclophosphamide/Doxorubicin/Fluorouracil/Levamisole Regimen;

NCIt synonyms : FAC-LEV Regimen; Cyclophosphamide/Doxorubicin/Fluorouracil/Levamisole; Cyclophosphamide-Doxorubicin-Fluorouracil-Levamisole; Cyclophosphamide-Doxorubicin-Fluorouracil-Levamisole Regimen; Fluorouracil/Adriamycin/Cyclophosphamide/Levamisole;

NCIt related terms : FAC-LEV;

NCIt definition : A regimen consisting of cyclophosphamide, doxorubicin, fluorouracil, and levamisole that may be used in the treatment of breast cancer.;

NCI Metathesaurus CUI : CL970515;

Détails

Origin ID

C161967;

UMLS CUI

C5206217;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Fluorouracil [NCIt concept]
- Levamisole Hydrochloride [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients